Adam R. Johnson

4.3k citations

49 papers · 1.2k indexed · h-index 21

Co-authors: A. C. Fogerty Leon Singer Richard D. Dyer F. S. Shenstone W. D. Armstrong Christine Everett R. Bickerstaffe Harvey Wong
Topics: Retinoids in leukemia and cellular processes (6 papers)Lipid metabolism and biosynthesis (4 papers)Chronic Lymphocytic Leukemia Research (3 papers)
Cited by: Cancer Research Biochemistry Oncology
Journals: Science Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United States Australia United Kingdom

In The Last Decade

Adam R. Johnson

48 papers receiving 1.2k citations

Peers

Countries citing papers authored by Adam R. Johnson

Since Specialization

Citations

This map shows the geographic impact of Adam R. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam R. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam R. Johnson more than expected).

Fields of papers citing papers by Adam R. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam R. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam R. Johnson. The network helps show where Adam R. Johnson may publish in the future.

Co-authorship network of co-authors of Adam R. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Adam R. Johnson. A scholar is included among the top collaborators of Adam R. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam R. Johnson. Adam R. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bruton’s Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in Rats 2016 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown),Leah Schutt,Jacqueline M. Tarrant,Michelle McDowell,Lichuan Liu,Adam R. Johnson,Sock-Cheng Lewin-Koh,Maj Hedehus,Jed Ross,Richard A.D. Carano,Karin Staflin,Fiona Zhong,James J. Crawford,(unknown),Karin Reif,Arna Katewa,Harvey Wong,Wendy B. Young,Donna M. Dambach,Dinah Misner	12
2	Discovery of oxa-sultams as RORc inverse agonists showing reduced lipophilicity, improved selectivity and favorable ADME properties 2016 ·Bioorganic & Medicinal Chemistry Letters ·Olivier René,Benjamin P. Fauber,(unknown),Kerry L. Chapman,Yuzhong Deng,Céline Eidenschenk,Christine Everett,Alberto Gobbi,Adam R. Johnson,Hank La,Maxine Norman,Gary Salmon,(unknown),Harvey Wong	9
3	Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists 2015 ·Bioorganic & Medicinal Chemistry Letters ·Benjamin P. Fauber,Alberto Gobbi,Kirk Robarge,Aihe Zhou,(unknown),Jianhua Cao,Yuzhong Deng,Céline Eidenschenk,Christine Everett,(unknown),Julie A. Hawkins,Adam R. Johnson,Hank La,Maxine Norman,Gary Salmon,(unknown),Wenjun Ouyang,Wei Tang,Harvey Wong	58
4	Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists 2015 ·Bioorganic & Medicinal Chemistry Letters ·Benjamin P. Fauber,Alberto Gobbi,Pascal Savy,Brenda Burton,Yuzhong Deng,Christine Everett,Hank La,Adam R. Johnson,Peter Lockey,Maxine Norman,Harvey Wong	10
5	Discovery of 1-{4-[3-Fluoro-4-((3 S ,6 R )-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist 2015 ·Journal of Medicinal Chemistry ·Benjamin P. Fauber,Olivier René,Yuzhong Deng,Jason DeVoss,Céline Eidenschenk,Christine Everett,(unknown),Alberto Gobbi,Julie A. Hawkins,Adam R. Johnson,Hank La,Justin Lesch,Peter Lockey,Maxine Norman,Wenjun Ouyang,(unknown),Harvey Wong	46
6	Identification of tertiary sulfonamides as RORc inverse agonists 2014 ·Bioorganic & Medicinal Chemistry Letters ·Benjamin P. Fauber,Olivier René,Brenda Burton,Christine Everett,Alberto Gobbi,Julie A. Hawkins,Adam R. Johnson,Marya Liimatta,Peter Lockey,Maxine Norman,Harvey Wong	22
7	Reduction in lipophilicity improved the solubility, plasma–protein binding, and permeability of tertiary sulfonamide RORc inverse agonists 2014 ·Bioorganic & Medicinal Chemistry Letters ·Benjamin P. Fauber,Olivier René,Gladys de Leon Boenig,Brenda Burton,Yuzhong Deng,Céline Eidenschenk,Christine Everett,Alberto Gobbi,S.G. Hymowitz,Adam R. Johnson,Hank La,Marya Liimatta,Peter Lockey,Maxine Norman,Wenjun Ouyang,Weiru Wang,Harvey Wong	39
8	Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc 2013 ·Bioorganic & Medicinal Chemistry Letters ·Benjamin P. Fauber,Gladys de Leon Boenig,Brenda Burton,Céline Eidenschenk,Christine Everett,Alberto Gobbi,S.G. Hymowitz,Adam R. Johnson,Marya Liimatta,Peter Lockey,Maxine Norman,Wenjun Ouyang,Olivier René,Harvey Wong	49
9	Gastrocnemius Recession or Tendo-Achilles Lengthening for Equinus Deformity in the Diabetic Foot? 2012 ·Clinics in Podiatric Medicine and Surgery ·Robert M. Greenhagen,Adam R. Johnson,Nicholas J. Bevilacqua	27
10	The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site 2012 ·Structure ·(unknown),Krista K. Bowman,Jianwen A. Feng,Terry D. Crawford,Christine Everett,Yvonne Franke,Angela Oh,Mark Stanley,Steven T. Staben,Melissa A. Starovasnik,Heidi J.A. Wallweber,Jian Wu,Lawren C. Wu,Adam R. Johnson,S.G. Hymowitz	50
11	Case Studies of Minimizing Nonspecific Inhibitors in HTS Campaigns That Use Assay-Ready Plates 2011 ·SLAS DISCOVERY ·Yichin Liu,Maureen H. Beresini,Adam R. Johnson,Robert A. Mintzer,(unknown),Kevin Clark,(unknown),Cristina Lewis,Marya Liimatta,Linda O. Elliott,Amy Gustafson,Christopher E. Heise	7
12	Idiopathic loss of deciduous teeth and associated alveolus 2010 ·UCL Discovery (University College London) ·(unknown),(unknown),Adam R. Johnson,(unknown)	2
13	Gastrocnemius Recession as an Alternative to TendoAchillis Lengthening for Relief of Forefoot Pressure in a Patient with Peripheral Neuropathy: A Case Report and Description of a Technical Modification 2010 ·The Journal of Foot & Ankle Surgery ·Robert M. Greenhagen,Adam R. Johnson,Matthew C. Peterson,Lee C. Rogers,Nicholas J. Bevilacqua	24
14	Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects 2007 ·Journal of Biological Chemistry ·Adam R. Johnson,A.G. Pavlovsky,Daniel F. Ortwine,(unknown),(unknown),Dirk A. Bornemeier,Craig Banotai,W. Thomas Mueller,Patrick McConnell,Chunhong Yan,Vijay Baragi,Charles A. Lesch,W. Howard Roark,Michael J. Wilson,Kaushik Datta,Roberto E. Guzman,Hyo‐Kyung Han,Richard D. Dyer	176
15	A Rationalization of the Acidic pH Dependence for Stromelysin-1 (Matrix Metalloproteinase-3) Catalysis and Inhibition 2000 ·Journal of Biological Chemistry ·Linda L. Johnson,A.G. Pavlovsky,Adam R. Johnson,(unknown),(unknown),Daniel F. Ortwine,(unknown),Andrew D. White,Donald Hupe	64
16	Site-Directed Mutagenesis of Histidine-90 inEscherichia colil-Threonine Dehydrogenase Alters Its Substrate Specificity 1998 ·Archives of Biochemistry and Biophysics ·Adam R. Johnson,Eugene E. Dekker	9
17	Effect of paroxetine, a selective 5-hydroxytryptamine uptake inhibitor, on β-adrenoceptors in rat brain: Autoradiographic and functional studies 1991 ·Neuropharmacology ·David J. Nelson,Gerard D. Pratt,(unknown),Adam R. Johnson,Norman G. Bowery	20
18	Influence of nutritional factors on the yield and content of milk fat: protected polyunsaturated fat in the diet. 1980 ·Bulletin. International Dairy Federation ·A. C. Fogerty,Adam R. Johnson	6
19	Inhibition by cyclopropene fatty acids of the desaturation of stearic acid in hen liver 1967 ·Lipids ·(unknown),Adam R. Johnson,A. C. Fogerty,Judith A. Pearson,F. S. Shenstone	60
20	The relationship of calcium and strontium in the mineralized tissues of the rat: replacement and exchange of these elements in vivo and in vitro. 1966 ·Adam R. Johnson	1

About Adam R. Johnson

Adam R. Johnson is a scholar working on Biochemistry, Equine and Oncology, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (6 papers), Lipid metabolism and biosynthesis (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Cancer Research (263 citations), Biochemistry (91 citations) and Oncology (300 citations). Adam R. Johnson has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include A. C. Fogerty, Leon Singer, Richard D. Dyer, F. S. Shenstone, W. D. Armstrong, Christine Everett, R. Bickerstaffe, Harvey Wong, Judith A. Pearson and Alberto Gobbi. Their work appears in journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact